Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer’s and cat allergy

Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes

(2016) Claudia Cavelti-Weder et al.   MOLECULAR THERAPY

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

(2016) Jeff Sevigny et al.   NATURE

Beyond passive immunization: toward a nanoparticle-based IL-17 vaccine as first in class of future immune treatments

(2015) John Foerster et al.   Nanomedicine

Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs

(2014) Ludger Klimek et al.   Expert Review of Clinical Immunology

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

(2014) Rachelle S. Doody et al.   NEW ENGLAND JOURNAL OF MEDICINE

IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms

(2014) H.-L. Ha et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Cucumber Mosaic Virus Based Expression System for the Production of Porcine Circovirus Specific Vaccines

(2012) Ákos Gellért et al.   PLoS One

The EP3-agonist sulprostone, but not prosta glandin E2 potentiates platelet aggregation in human blood

(2010) Lisa Schober et al.   THROMBOSIS AND HAEMOSTASIS

The Major Cat Allergen, Fel d 1, in Diagnosis and Therapy

(2009) Hans Grönlund et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy

(2009) Nicole Schmitz et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Alveolar Macrophages and Lung Dendritic Cells Sense RNA and Drive Mucosal IgA Responses

(2009) J. Bessa et al.   JOURNAL OF IMMUNOLOGY

IFN  kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model

(2009) D. Zagury et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Immunodrugs: Therapeutic VLP-Based Vaccines for Chronic Diseases

(2008) Gary T. Jennings et al.   Annual Review of Pharmacology and Toxicology

The coming of age of virus-like particle vaccines

(2008) Gary T. Jennings et al.   BIOLOGICAL CHEMISTRY

Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study

(2008) Alain C Tissot et al.   LANCET

Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design

(2007) Juliana Bessa et al.   EUROPEAN JOURNAL OF IMMUNOLOGY